News / Science & Technology

South Korean Lab Focuses on Neglected Diseases

A branch of a French research institute is developing new drugs to combat diseases mainly afflicting developing countries - including so-called neglected diseases, which kill millions of people each year. These diseases range from parasitic infections like sleeping sickness, to viral maladies like dengue fever. They typically get less attention from international drug companies looking to develop treatments that can generate larger profits.

There have been breakthroughs in fighting some of the world’s most serious and common diseases, thanks to start-up funding from South Korea’s science ministry, along with contributions from non-government groups in the United States, France and other countries.

Combining imaging technology and biotechnology, scientists are now able to witness infections as they occur, in real time.

Ulf Nehrbass calls it a "game-changer" for developing new drugs. He is the chief executive officer of the South Korean branch of the 124-year-old Institut Pasteur [IPK].

"We have been, for the first time, able to reconstitute this, to have pathogens in live human cells and we image that. We look at the infection as it happens. That’s entirely new. And so this has allowed us to develop drugs which are effective in a complex, very realistic system," said Nehrbass.

One of the targets is tuberculosis, a disease that has plagued humans since they lived in caves. It remains very difficult to treat. Patients must gobble handfuls of slow-acting and toxic pills for between six months and two years.

Kevin Pethe leads one of the IPK early discovery program groups, which is examining natural compounds and synthetic candidates to find better treatments.

"There are at least 300 or 400 natural compounds that are currently used in the fight against tuberculosis," said Pethe. "So we look at both. So we are very opportunistic."  

Lawrence Ayong from Cameroon leads a team seeking new drugs to battle endemic tropical diseases, such as malaria.

"Then inside the red blood cells you see the yellow color, which indicates the presence of parasites," said Ayong.

One of their biggest frustrations is that dangerous organisms are able to evolve and outwit the drugs designed to kill them.

"Here we are focused in developing innovative approaches that can help limit the spread of these drug-resistant parasites, be it in malaria, in leishmaniasis or chagas," he said.

Ayong has a warning for those in the developed world who believe neglected diseases are of no concern for them.

"With globalization it doesn’t matter where the disease is located. It’s going to affect everybody economically and even socially. So, I think the time is now for all of us to join efforts against all these diseases," said Ayong.

Outside of several U.N.-backed partnerships, the best laboratories in the world are not part of those efforts. They belong to the giant for-profit pharmaceutical companies.

Institut Pasteur Korea CEO Nehrbass said those corporations devote the bulk of their research budgets to finding blockbuster drugs, which could ring up billions of dollars in profits.

"Most of the infectious diseases, even the neglected diseases, do not fall under that category. There is a huge need, however. And I think we need to look at a new model of entities, new platforms that have to develop drugs in these areas, new public-private partnerships," said Nehrbass.

In the current economic climate even the most generous of philanthropists are streamlining contributions. That has researchers nervous that their money could run out before they are able to develop new and effective drugs targeting neglected diseases, a process that can take years, if not decades.


Steve Herman

A veteran journalist, Steven L Herman is the Voice of America Asia correspondent.

You May Like

EU Court Fines Poland for Hosting CIA 'Black Sites'

Ruling is first time a court has acknowledged suspects were held and tortured at the sites, under US program launched following the 9/11 terrorist attacks More

Migrant Issues Close to Home Spur Groups to Take Action

Groups placing water, food in the desert, or aiding detainees after release, have one common goal: no more deaths of migrants crossing illegally into the US More

Video At AIDS Conference, Prevention Pill Stirs Excitement

Truveda shows promise, spurring debate over access and other approaches More

This forum has been closed.
Comments
     
There are no comments in this forum. Be first and add one

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Treatment for Childhood Epilepsy Heats up Medical Marijuana Debatei
X
Shelley Schlender
July 24, 2014 6:43 PM
In the United States, marijuana is classed as an illegal drug by the federal government. But nearly half the states have legalized it, to some degree. Proponents say some strains of marijuana might have exceptional health benefits, for treating pain or inflammation in chronic conditions such as cancer, multiple sclerosis and epilepsy. Shelley Schlender reports on a strain of medical marijuana developed in Colorado that is reputed to reduce seizures in childhood epilepsy
Video

Video Treatment for Childhood Epilepsy Heats up Medical Marijuana Debate

In the United States, marijuana is classed as an illegal drug by the federal government. But nearly half the states have legalized it, to some degree. Proponents say some strains of marijuana might have exceptional health benefits, for treating pain or inflammation in chronic conditions such as cancer, multiple sclerosis and epilepsy. Shelley Schlender reports on a strain of medical marijuana developed in Colorado that is reputed to reduce seizures in childhood epilepsy
Video

Video Airbus Adds Metal 3D Printed Parts to New Jets

By the end of this year, European aircraft manufacturing consortium Airbus plans to deliver the first of its new, extra-wide-body passenger jets, the A350-XWB. Among other technological innovations, the new plane will also incorporate metal parts made in a 3-D printer. VOA's George Putic has more.
Video

Video Death Toll From Israel-Gaza Conflict Surpasses 700

Gaza officials say a shelling hit a compound housing a United Nations-run school in the Gaza Strip, killing more than a dozen people, during an Israeli offensive in the area. Heavy fighting between the Israeli military and Hamas militants continued on Thursday, pushing up the death toll. So far, more than 730 Palestinians and 35 Israelis have been killed in the conflict. VOA's Scott Bobb has the latest from Jerusalem.
Video

Video AIDS Conference Welcomes Exciting Developments in HIV Treatment, Prevention

Significant strides have been made in recent years toward the treatment and prevention of HIV, the virus that causes AIDS. This year, at the International AIDS Conference, the AIDS community welcomed progress on a new pill that may prevent transmission of the deadly virus. VOA’s Anita Powell reports from Melbourne, Australia.
Video

Video Israel Targets Gaza Supply Tunnels

The Israeli military has launched a ground operation in Gaza to destroy the myriad tunnels that may have been used to smuggle weapons to Hamas. VOA's Zlatica Hoke reports that could mean more hardship for the people of Gaza, who obtain some of their essential supplies through these underground passages
Video

Video Researchers Target Low-Cost Avatar Technology

Scientists at the University of Southern California Institute for Creative Technologies say 3-dimensional representations could revolutionize social media. Elizabeth Lee has more from Los Angeles.
Video

Video IAEA: Iran Turns its Enriched Uranium Into Less Harmful Form

Iran has converted its stockpiles of enriched uranium into a less dangerous form that is more difficult to use for nuclear weapons, according to the United Nations’ Atomic Energy Agency. The move complies with an interim deal reached with Western powers on Iran's nuclear program last year, in exchange for easing of sanctions. Henry Ridgwell reports for VOA from London.
Video

Video In Cambodia, HIV Diagnosis Brings Deadly Shame

Although HIV/AIDS is now a treatable condition, a positive diagnosis is still a life altering experience. In Cambodia, people living with HIV are often disowned by friends, family and the community. This humiliation can be unbearable. We bring you one Cambodian woman’s struggle to overcome a life tragedy and her own HIV positive diagnosis.

AppleAndroid